Sectors
GENB
Generate Biomedicines, Inc.
13.97
1 x 13.95
1 x 13.98
bid
ask
-
0.42
2.92%
01:07 PM
timesize
| Ytd | 10.43% | |
| 1y | 10.43% |
13.92
day range
14.40
11.00
52 week range
18.18
| Open | 14.22 | Prev Close | 14.39 | Low | 13.92 | High | 14.40 | Mkt Cap | 1.84B |
| Vol | 94.49K | Avg Vol | 786.60K | EPS | -2.08 | P/E | -6.92 | Forward P/E | -7.61 |
| Beta | N/A | Short Ratio | 4.88 | Inst. Own | 72.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 14.42 | 200-d Avg | 13.50 | 1yr Est | 25.40 |
| Income Statement | |||
| Total Revenue | 7.22M | ||
| Revenues (USD) | 7.22M | ||
| Gross Profit | 7.22M | ||
| Operating Expenses | 71.34M | ||
| Research and Development Expense | 57.81M | ||
| Selling, General and Administrative Expense | 13.52M | ||
| Operating Income | -64.11M | ||
| Interest Expense | 182.00K | ||
| Income Tax Expense | 28.00K | ||
| Net Income | -61.45M | ||
| Net Income Common Stock | -69.19M | ||
| Net Income Common Stock (USD) | -69.19M | ||
| Consolidated Income | -61.71M | ||
| Net Income to Non-Controlling Interests | -268.00K | ||
| Earnings per Basic Share | -1.07 | ||
| Earnings per Basic Share (USD) | -1.07 | ||
| Earnings per Diluted Share | -1.07 | ||
| Earning Before Interest & Taxes (EBIT) | -61.24M | ||
| Earning Before Interest & Taxes (USD) | -61.24M | ||
| Preferred Dividends Income Statement Impact | 7.75M | ||
| Weighted Average Shares | 64.87M | ||
| Weighted Average Shares Diluted | 64.87M | ||
| Balance Sheet | |||
| Cash and Equivalents | 160.57M | ||
| Cash and Equivalents (USD) | 160.57M | ||
| Investments | 356.07M | ||
| Investments Current | 356.07M | ||
| Current Assets | 535.39M | ||
| Property, Plant & Equipment Net | 85.60M | ||
| Total Assets | 625.74M | ||
| Debt Current | 14.26M | ||
| Total Debt | 65.57M | ||
| Current Liabilities | 58.39M | ||
| Debt Non-Current | 51.31M | ||
| Total Liabilities | 110.94M | ||
| Accumulated Retained Earnings (Deficit) | -737.74M | ||
| Accumulated Other Comprehensive Income | 24.00K | ||
| Shareholders Equity | 514.80M | ||
| Shareholders Equity (USD) | 514.80M | ||
| Assets Non-Current | 90.35M | ||
| Total Debt (USD) | 65.57M | ||
| Deferred Revenue | 18.48M | ||
| Liabilities Non-Current | 52.55M | ||
| Trade and Non-Trade Payables | 7.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.37M | ||
| Net Cash Flow from Financing | 378.89M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 38.57M | ||
| Capital Expenditure | -3.78M | ||
| Issuance (Purchase) of Equity Shares | 372.51M | ||
| Issuance (Repayment) of Debt Securities | -1.11M | ||
| Net Cash Flow from Investing | -259.93M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -256.15M | ||
| Net Cash Flow from Operations | -80.39M | ||
| Share Based Compensation | 6.40M | ||